Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$753K Buy
6,264
+35
+0.6% +$4.04K 0.41% 65
2025
Q4
$656K Sell
6,229
-338
-5% -$31.7K 0.35% 75
2025
Q3
$551K Sell
6,567
-93
-1% -$7.66K 0.31% 76
2025
Q2
$527K Sell
6,660
-374
-5% -$29.7K 0.4% 70
2025
Q1
$700K Hold
7,034
0.46% 54
2024
Q4
$700K Buy
+7,034
New +$725K 0.46% 54

Other funds holding MRK

Claris Financial's MRK Position: Q1 2026 in Review

Claris Financial increased its Merck (MRK) stake by 0.56% in Q1 2026, buying an estimated $4.04K and bringing the position to 6,264 shares worth $753K. The position accounts for 0.41% of the portfolio, ranked #65.

Claris Financial first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Claris Financial held 6,264 shares of Merck worth $753K as of Q1 2026.
  • Claris Financial bought 35 Merck shares in Q1 2026, an estimated $4.04K.
  • Merck made up 0.41% of Claris Financial's portfolio in Q1 2026, its #65 holding.
  • Claris Financial first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Claris Financial's 13F filing for Q1 2026, filed 18 May 2026.